Idel raises $10.4M for intracellular pan-cancer drug delivery tech

AI Briefing

• – Idel raises $10.4M for intracellular pan-cancer drug delivery tech.
• – Technology aims to target previously undruggable cancer cells
• – Funding will advance development of cytotoxic drugs